Singh Gyanendra, Singh Usha, Singh S K, Singh Shailja
Department of Pathology, Institute of Medical Sciences, BHU, Varanasi, Uttar Pradesh, India.
Department of Endocrinology and, Institute of Medical Sciences, BHU, Varanasi, Uttar Pradesh, India.
Indian J Endocrinol Metab. 2020 Jul-Aug;24(4):325-332. doi: 10.4103/ijem.IJEM_564_19. Epub 2020 Aug 27.
Type-1 diabetes mellitus (T1DM) which is also known as insulin-dependent diabetes is diagnosed mainly during childhood and accounts for approximately 5%-10% of all cases of DM. In India, early onset diabetes (<15 years age) constitutes about 1%-4% of the total diabetic population. The insulitis as well as to a humoral (B cell) response with production of antibodies to IAA, GAD, and the protein tyrosine phosphatase IA2 (IA-2AA) is the main pathogenesis of T1DM. Human leukocyte antigen (HLA)-DR and DQ contributes approximately 40%-50% of the inherited susceptibility for T1DM and most frequently involved haplotypes are DRB10301-DQB10201, DRB10301-DQA10501-DQB10201, and DRB10401-DQB1*0302.
Total 70 cases of DM in age group of 10 years to 65 years and 25 healthy controls of same age group 30 cases of complicated diabetic mellitus were included in the study. 2 mL blood was taken in an EDTA vial for HLA typing and 5 mL blood was taken in a plain vial for anti-GAD antibody. HLA DQB1 and DRB1 were done by sequence specific priming polymerase chain reaction method. Indirect immunofluorescent test was used for anti-GAD antibody. Statistical analysis was performed using SPSS version-16.
Total 40.9% cases of type-I DM were found seropositive for anti-GAD antibody. None of the cases of type-II DM was anti-GAD antibody positive. HLA DRB103010 were significantly more in diabetic patient ( < 0.011) as compared to control. DRB1O403/6 shows that a relative risk of 1.08 was slightly more frequent in DM cases as compared to the control. DQB10201 was significantly high ( < 0.004) in DM patient as compared to control with a relative risk of 1.68. Correlation of DR, DQ antigen with types of DM showed that in type-I DM, DRB103010 was significantly high ( = 0.009) with a relative risk of 2.78 as compared type-II DM. In DQ typing, DQB10201 was significantly high in type-I DM in comparison to type-II DM (65% vs. 30%, = 0.026, RR = 2.05). Comparison of DQB1 in type-I DM with healthy control showed that DQB10201 was significantly high in type-I DM as compared to healthy control ( = 0.0003, RR = 3.09). In type-I DM patient's homozygosity at DRB103010, DRB103010 was significantly high as compared to the control ( < 0.047, RR = 2.33). Correlation of anti-GAD antibody with DRB1 and DQB1 showed that 77.7% anti-GAD antibody positive cases were DRB103010 positive. Similarly, in DQB1 typing, 66.6% anti-GAD positive cases have DQB10201.
Prevalence of anti-GAD antibody in Indian population was found up to 45%. HLA DRB13010 and HLA DQB10201 were the most susceptible haplotypes for type-I DM. HLA DRB114 and HLA DRB115 were the protective haplotypes for type-I DM. Susceptibility to type-I DM increases when the homozygosity for DRB1*03010 was present. Diagnosis of type-I DM by anti-GAD antibody was possible in only 40.9% cases but if DRB1 and DQB1 typing is added in the diagnosis then diagnostic efficacy increases up to 83%.
1型糖尿病(T1DM),也称为胰岛素依赖型糖尿病,主要在儿童期被诊断出来,约占所有糖尿病病例的5%-10%。在印度,早发性糖尿病(<15岁)约占糖尿病总人口的1%-4%。胰岛炎以及针对胰岛素自身抗体(IAA)、谷氨酸脱羧酶抗体(GAD)和蛋白酪氨酸磷酸酶IA2抗体(IA-2AA)产生的体液(B细胞)反应是T1DM的主要发病机制。人类白细胞抗原(HLA)-DR和DQ约占T1DM遗传易感性的40%-50%,最常见的单倍型是DRB10301-DQB10201、DRB10301-DQA10501-DQB10201和DRB10401-DQB1*0302。
本研究纳入了年龄在10岁至65岁的70例糖尿病患者以及同年龄组的25例健康对照,其中30例为糖尿病并发症患者。采集2mL血液于EDTA抗凝管中用于HLA分型,采集5mL血液于普通管中用于检测抗GAD抗体。采用序列特异性引物聚合酶链反应法检测HLA DQB1和DRB1。采用间接免疫荧光试验检测抗GAD抗体。使用SPSS 16.0版软件进行统计分析。
发现40.9%的1型糖尿病患者抗GAD抗体呈血清阳性。2型糖尿病患者中无一例抗GAD抗体呈阳性。与对照组相比,糖尿病患者中HLA DRB103010显著增多(<0.011)。DRB1O403/6显示糖尿病患者的相对风险为1.08,略高于对照组。与对照组相比.DQB10201在糖尿病患者中显著增高(<0.004),相对风险为1.68。DR及DQ抗原与糖尿病类型的相关性显示,在1型糖尿病中,DRB103010显著增高(=0.009),与2型糖尿病相比相对风险为2.78。在DQ分型中,与2型糖尿病相比,DQB10201在1型糖尿病中显著增高(65%对30%,=0.026,RR=2.05)。1型糖尿病患者与健康对照的DQB1比较显示,与健康对照相比,DQB10201在1型糖尿病中显著增高(=0.0003,RR=3.09)。在1型糖尿病患者中,DRB103010纯合子与对照组相比,DRB03010显著增高(<0.047,RR=2.33)。抗GAD抗体与DRB1和DQB1的相关性显示,77.7%抗GAD抗体阳性病例DRB103010呈阳性。同样,在DQB1分型中,66.6%抗GAD阳性病例具有DQB10201。
在印度人群中抗GAD抗体的患病率高达45%。HLA DRB13010和HLA DQB10201是1型糖尿病最易感的单倍型。HLA DRB114和HLA DRB115是1型糖尿病的保护性单倍型。当存在DRB1*03010纯合子时,1型糖尿病的易感性增加。仅通过抗GAD抗体诊断1型糖尿病仅在40.9%的病例中可行,但如果在诊断中加入DRB1和DQB1分型,则诊断效率可提高至83%。